Cite
P-183 Neoadjuvant treatment in borderline resectable pancreatic adenocarcinoma (PA): A single center series
MLA
Teresa Serrano, et al. “P-183 Neoadjuvant Treatment in Borderline Resectable Pancreatic Adenocarcinoma (PA): A Single Center Series.” Annals of Oncology, vol. 26, June 2015, p. iv53. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........abf5dd492d4079c0d9f9aceb1029428b&authtype=sso&custid=ns315887.
APA
Teresa Serrano, Joan Fabregat, Mariona Calvo, C. Sánchez, S. Ruiz, Saulo A. Vázquez, D. Leiva, M. Galán, R. Lopez Urdiales, Olbia Serra, Luis Secanella, I. Peiro, Berta Laquente, M. Cambray, H. Verdaguer Mata, F.J. Pérez Martín, J Busquets, & Núria Peláez. (2015). P-183 Neoadjuvant treatment in borderline resectable pancreatic adenocarcinoma (PA): A single center series. Annals of Oncology, 26, iv53.
Chicago
Teresa Serrano, Joan Fabregat, Mariona Calvo, C. Sánchez, S. Ruiz, Saulo A. Vázquez, D. Leiva, et al. 2015. “P-183 Neoadjuvant Treatment in Borderline Resectable Pancreatic Adenocarcinoma (PA): A Single Center Series.” Annals of Oncology 26 (June): iv53. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........abf5dd492d4079c0d9f9aceb1029428b&authtype=sso&custid=ns315887.